-
Reviews
Back to Reviews
Previous Version:
Phytopharmaceuticals in the Therapy of Younger Alzheimer Patients
-
Other Comments:
I found it very informative, You can add more regarding "targeted drug delivery using Plant made CCS" because most of issues regarding plant drugs is drug delivery especially in their formulation because drug stablity is an issue. You can also give insights to future experimental methods like how to express or seperate properly folded recombinant therapeutic proteins from that of misfolded one because there are millions of compounds or proteins that can be explored but to extract that particular compound or protein is even more challenging and expensive say for a large scale production.
-
Invited by the author to review this article? :
Yes -
Have you previously published on this or a similar topic?:
Yes
-
References:
None -
Experience and credentials in the specific area of science:
I have worked on wound healing studies using plant extract which was formulated to topical gel
- How to cite: Sainuddin T .Very informative[Review of the article 'Phytopharmaceuticals in the Therapy of Younger Alzheimer Patients ' by Kastenholz B].WebmedCentral 2012;2(3):WMCRW00625
The article discusses the use of plant extracts such as ginko biloba and its derivatives in the treatment of dementia, particularly in the under 50 years old. It emphasisis the use of ingredients other than phlavoonoids and terpenoids.
Yes
Yes
Yes
Yes
Yes
See below
The approach that considers the role of metals in dementia is not novel, but the potential benefits of gingko biloba in this respect ares interesting
It would be useful if this was followed by a clinic trial showing the benefits of the treatment, and slo suggest more practical ways of how to use the treatment, beyond the use of normal over-the-counter ginkgo biloba extracts.
No
No
Yes
Stay Young Longer (Vega publishing 2001) and Elixirs of Youth (Watkins publisher 2005)
None